The Use of Zoledronic Acid in Men on Androgen Deprivation Therapy for Prostate Cancer With Preexisting Osteoporosis
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Nirmala Bhoopalam, MD
Hines VA Medical Center
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Southern Az Va Health Care System
Tucson, Arizona, United States
- Va Medical Center-Long Beach
Long Beach, California, United States
- Washington Va Medical Center
Washington D.C., District of Columbia, United States
- West Side Vmac
Chicago, Illinois, United States
- Hines Va Medical Center
Hines, Illinois, United States
- Kansas City Vmac
Kansas City, Missouri, United States
- Vawny Buffalo
Buffalo, New York, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2004
- Primary completion
- 31 Mar 2007
- Completion
- 31 Mar 2007
- Last update posted
- 23 Feb 2017
- Registered enrollment
- 28
- Registry id
- NCT00171639
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.